"Siemens" fructosamine reagent group - Taiwan Registration b140c90bec8265c7fda03a13561fe2c3
Access comprehensive regulatory information for "Siemens" fructosamine reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b140c90bec8265c7fda03a13561fe2c3 and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
b140c90bec8265c7fda03a13561fe2c3
DHA05603200504
Product Details
This product is used for in vitro diagnostics, and needs to be used with Atellica CH Analyzer to quantitatively detect glycated proteins (fructosamine) in human serum and plasma (heparin lithium, EDTA potassium salt).
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
A.1150 calibration;; B.7470 Analysis of glycosylated hemoglobin
Input;; Contract manufacturing
Dates and Status
Jan 07, 2019
Jan 07, 2029